Advertisement
Screener

SI-BONE, INC. (SIBN) Investing Cash Flow

3.7 / 5 stars · 44/60 Roast Me

SI-BONE, INC. Investing Cash Flow

SI-BONE, INC. (SIBN) reported Investing Cash Flow of -$8.97 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Cash Flow › Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-04

  • SI-BONE, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$2.74M.
  • SI-BONE, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$6.23M, a 158.63% decline year-over-year.
  • SI-BONE, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $13.03M, a 200.35% increase year-over-year.
  • SI-BONE, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$10.03M, a 365.99% decline year-over-year.
  • SI-BONE, INC. net cash provided by (used in) investing activities for fiscal 2025 was $4.16M, a 67.04% decline from fiscal 2024.
  • SI-BONE, INC. net cash provided by (used in) investing activities for fiscal 2024 was $12.62M.
  • SI-BONE, INC. net cash provided by (used in) investing activities for fiscal 2023 was -$59.80M.
  • SI-BONE, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$2.81M, a 105.46% decline from fiscal 2021.
Period endNet Cash Provided by (Used in) Investing Activities 3 monthNet Cash Provided by (Used in) Investing Activities 6 monthNet Cash Provided by (Used in) Investing Activities 9 monthNet Cash Provided by (Used in) Investing Activities 12 month
2026-06-30-$2.74M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
-$8.97M
10-Q · filed 2026-08-04
$4.06M
derived: sum of 3 quarters · filed 2026-08-04
-$5.97M
derived: sum of 4 quarters · filed 2026-08-04
2026-03-31-$6.23M
10-Q · filed 2026-05-11
$6.79M
derived: sum of 2 quarters · filed 2026-05-11
-$3.23M
derived: sum of 3 quarters · filed 2026-05-11
-$12.70M
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31$13.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$3.00M
derived: sum of 2 quarters · filed 2026-02-24
-$6.47M
derived: sum of 3 quarters · filed 2026-08-04
$4.16M
10-K · filed 2026-02-24
2025-09-30-$10.03M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
-$19.50M
derived: sum of 2 quarters · filed 2026-08-04
-$8.87M
10-Q · filed 2025-11-10
-$4.53M
derived: sum of 4 quarters · filed 2026-08-04
2025-06-30-$9.47M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
$1.16M
10-Q · filed 2026-08-04
$5.50M
derived: sum of 3 quarters · filed 2026-08-04
$9.27M
derived: sum of 4 quarters · filed 2026-08-04
2025-03-31$10.63M
10-Q · filed 2026-05-11
$14.97M
derived: sum of 2 quarters · filed 2026-05-11
$18.74M
derived: sum of 3 quarters · filed 2026-05-11
$16.91M
derived: sum of 4 quarters · filed 2026-05-11
2024-12-31$4.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$8.11M
derived: sum of 2 quarters · filed 2026-02-24
$6.28M
derived: sum of 3 quarters · filed 2026-02-24
$12.62M
10-K · filed 2026-02-24
2024-09-30$3.77M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
$1.94M
derived: sum of 2 quarters · filed 2025-11-10
$8.29M
10-Q · filed 2025-11-10
-$10.63M
derived: sum of 4 quarters · filed 2026-02-24
2024-06-30-$1.83M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05
$4.52M
10-Q · filed 2025-08-05
-$14.39M
derived: sum of 3 quarters · filed 2026-02-24
-$69.27M
derived: sum of 4 quarters · filed 2026-02-24
2024-03-31$6.35M
10-Q · filed 2025-05-06
-$12.56M
derived: sum of 2 quarters · filed 2026-02-24
-$67.44M
derived: sum of 3 quarters · filed 2026-02-24
-$65.15M
derived: sum of 4 quarters · filed 2026-02-24
2023-12-31-$18.91M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$73.78M
derived: sum of 2 quarters · filed 2026-02-24
-$71.50M
derived: sum of 3 quarters · filed 2026-02-24
-$59.80M
10-K · filed 2026-02-24
2023-09-30-$54.87M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
-$52.59M
derived: sum of 2 quarters · filed 2024-11-12
-$40.89M
10-Q · filed 2024-11-12
-$40.80M
derived: sum of 4 quarters · filed 2025-02-25
2023-06-30$2.28M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06
$13.98M
10-Q · filed 2024-08-06
$14.07M
derived: sum of 3 quarters · filed 2025-02-25
$22.80M
derived: sum of 4 quarters · filed 2025-02-25
2023-03-31$11.70M
10-Q · filed 2024-05-07
$11.79M
derived: sum of 2 quarters · filed 2025-02-25
$20.52M
derived: sum of 3 quarters · filed 2025-02-25
$31.50M
derived: sum of 4 quarters · filed 2025-02-25
2022-12-31$89.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25
$8.82M
derived: sum of 2 quarters · filed 2025-02-25
$19.79M
derived: sum of 3 quarters · filed 2025-02-25
-$2.81M
10-K · filed 2025-02-25
2022-09-30$8.73M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
$19.70M
derived: sum of 2 quarters · filed 2023-11-07
-$2.90M
10-Q · filed 2023-11-07
$12.47M
derived: sum of 4 quarters · filed 2023-11-07
2022-06-30$10.98M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
-$11.63M
10-Q · filed 2023-08-08
$3.75M
derived: sum of 3 quarters · filed 2023-08-08
$30.50M
derived: sum of 4 quarters · filed 2023-08-08
2022-03-31-$22.61M
10-Q · filed 2023-05-02
-$7.23M
derived: sum of 2 quarters · filed 2023-05-02
$19.52M
derived: sum of 3 quarters · filed 2023-05-02
$36.09M
derived: sum of 4 quarters · filed 2023-05-02
2021-12-31$15.38M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02
$42.13M
derived: sum of 2 quarters · filed 2023-03-02
$58.70M
derived: sum of 3 quarters · filed 2023-03-02
$51.58M
10-K · filed 2023-03-02
2021-09-30$26.75M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
$43.32M
derived: sum of 2 quarters · filed 2022-11-08
$36.20M
10-Q · filed 2022-11-08
-$31.62M
derived: sum of 4 quarters · filed 2022-11-08
2021-06-30$16.57M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
$9.45M
10-Q · filed 2022-08-09
-$58.37M
derived: sum of 3 quarters · filed 2022-08-09
-$63.53M
derived: sum of 4 quarters · filed 2022-08-09
2021-03-31-$7.12M
10-Q · filed 2022-05-10
-$74.94M
derived: sum of 2 quarters · filed 2022-05-10
-$80.10M
derived: sum of 3 quarters · filed 2022-05-10
-$73.38M
derived: sum of 4 quarters · filed 2022-05-10
2020-12-31-$67.82M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
-$72.98M
derived: sum of 2 quarters · filed 2022-03-01
-$66.25M
derived: sum of 3 quarters · filed 2022-03-01
-$62.92M
10-K · filed 2022-03-01
2020-09-30-$5.16M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
$1.56M
derived: sum of 2 quarters · filed 2021-11-09
$4.90M
10-Q · filed 2021-11-09
$10.48M
derived: sum of 4 quarters · filed 2021-11-09
2020-06-30$6.72M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04
$10.06M
10-Q · filed 2021-08-04
$15.63M
derived: sum of 3 quarters · filed 2021-08-04
$23.36M
derived: sum of 4 quarters · filed 2021-08-04
2020-03-31$3.34M
10-Q · filed 2021-05-04
$8.91M
derived: sum of 2 quarters · filed 2021-05-04
$16.64M
derived: sum of 3 quarters · filed 2021-05-04
$22.38M
derived: sum of 4 quarters · filed 2021-05-04
2019-12-31$5.58M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10
$13.30M
derived: sum of 2 quarters · filed 2021-03-10
$19.04M
derived: sum of 3 quarters · filed 2021-03-10
$13.49M
10-K · filed 2021-03-10
2019-09-30$7.72M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03
$13.47M
derived: sum of 2 quarters · filed 2020-11-03
$7.92M
10-Q · filed 2020-11-03
-$89.13M
derived: sum of 4 quarters · filed 2020-11-03
2019-06-30$5.74M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04
$191.00K
10-Q · filed 2020-08-04
-$96.86M
derived: sum of 3 quarters · filed 2020-08-04
-$96.92M
derived: sum of 4 quarters · filed 2020-08-04
2019-03-31-$5.55M
10-Q · filed 2020-05-05
-$102.60M
derived: sum of 2 quarters · filed 2020-05-05
-$102.66M
derived: sum of 3 quarters · filed 2020-05-05
-$103.16M
derived: sum of 4 quarters · filed 2020-05-05
2018-12-31-$97.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11
-$97.11M
derived: sum of 2 quarters · filed 2020-03-11
-$97.61M
derived: sum of 3 quarters · filed 2020-03-11
-$97.83M
10-K · filed 2020-03-11
2018-09-30-$62.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
-$559.00K
derived: sum of 2 quarters · filed 2019-11-12
-$777.00K
10-Q · filed 2019-11-12
-$885.00K
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30-$497.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
-$715.00K
10-Q · filed 2019-08-07
-$823.00K
derived: sum of 3 quarters · filed 2019-08-07
2018-03-31-$218.00K
10-Q · filed 2019-05-09
-$326.00K
derived: sum of 2 quarters · filed 2019-05-09
2017-12-31-$108.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14
-$478.00K
10-K · filed 2019-03-14
2017-09-30-$370.00K
10-Q · filed 2018-11-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
SpyGlass Pharma, Inc. (SGP)United States$0.925B
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
ANGIODYNAMICS INC (ANGO)United States$0.632B-13.02
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B
SS Innovations International, Inc. (SSII)$0.589B-64.06
IRADIMED CORP (IRMD)United States$1.089B52.92
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33